Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297603
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-03-01
Brief Title:
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment With Inadequate Glycemic Control on Basal Insulin With or Without Metformin andor SGLT2 Inhibitor TRANSCEND-T2D-3
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-01
First Submit QC Date:
March 1 2024
Study First Post Date:
2024-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL